Morgan Stanley Tela Bio, Inc. Transaction History

Morgan Stanley

$1.49 Trillion
Q2 2025

A detailed history of Morgan Stanley transactions in Tela Bio, Inc. stock. As of the latest transaction made, Morgan Stanley holds 2,219 shares of TELA stock, worth $3,594. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,219

Previous 39,120 94.33%

Holding current value

$3,594

Previous $47,000 91.49%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	SELL	$0.89 - $1.95 $32,841 - $71,956	-36,901 Reduced 94.33%	2,219 $4,000
Q1 2025 May 15, 2025	BUY	$1.22 - $2.91 $25,983 - $61,977	21,298 Added 119.5%	39,120 $47,000
Q4 2024 Feb 14, 2025	BUY	$2.38 - $3.14 $37,132 - $48,990	15,602 Added 702.79%	17,822 $53,000
Q3 2024 May 14, 2025	SELL	$2.32 - $5.04 $40,361 - $87,680	-17,397 Reduced 88.68%	2,220 $5,000
Q3 2024 Nov 14, 2024	SELL	$2.32 - $5.04 $40,361 - $87,680	-17,397 Reduced 88.68%	2,220 $5,000
Q2 2024 May 14, 2025	BUY	$4.39 - $6.36 $7,880 - $11,416	1,795 Added 10.07%	19,617 $92,000
Q2 2024 Oct 17, 2024	SELL	$4.39 - $6.36 $143,886 - $208,455	-32,776 Reduced 62.56%	19,617 $92,000
Q2 2024 Aug 14, 2024	SELL	$4.39 - $6.36 $143,886 - $208,455	-32,776 Reduced 62.56%	19,617 $92,000
Q1 2024 Oct 17, 2024	BUY	$5.3 - $7.61 $173,712 - $249,425	32,776 Added 167.08%	52,393 $297,000
Q1 2024 Aug 16, 2024	SELL	$5.3 - $7.61 $200,488 - $287,871	-37,828 Reduced 41.93%	52,393 $297,000
Q1 2024 May 15, 2024	SELL	$5.3 - $7.61 $200,488 - $287,871	-37,828 Reduced 41.93%	52,393 $297,000
Q4 2023 Aug 16, 2024	BUY	$4.5 - $7.51 $317,718 - $530,236	70,604 Added 359.91%	90,221 $597,000
Q4 2023 Feb 13, 2024	BUY	$4.5 - $7.51 $370,480 - $618,290	82,329 Added 1043.2%	90,221 $597,000
Q3 2023 Nov 15, 2023	SELL	$7.85 - $10.68 $27,639 - $37,604	-3,521 Reduced 30.85%	7,892 $63,000
Q2 2023 Aug 14, 2023	SELL	$9.23 - $11.23 $27,911 - $33,959	-3,024 Reduced 20.95%	11,413 $115,000
Q1 2023 May 15, 2023	BUY	$9.41 - $12.03 $92,029 - $117,653	9,780 Added 210.01%	14,437 $153,000
Q4 2022 Feb 14, 2023	BUY	$6.5 - $11.5 $30,192 - $53,417	4,645 Added 38708.33%	4,657 $53,000
Q3 2022 Nov 14, 2022	BUY	$7.36 - $9.15 $88 - $109	12 New	12 $0
Q2 2022 Aug 15, 2022	SELL	$5.54 - $11.49 $1,141 - $2,366	-206 Closed	0 $0
Q1 2022 Oct 27, 2022	BUY	$11.35 - $13.7 $2,338 - $2,822	206 New	206 $2,000
Q1 2022 May 13, 2022	BUY	$11.35 - $13.7 $1,940 - $2,342	171 Added 488.57%	206 $2,000
Q4 2021 Feb 14, 2022	BUY	$11.95 - $13.34 $23 - $26	2 Added 6.06%	35 $0
Q3 2021 Nov 15, 2021	BUY	$12.2 - $15.93 $402 - $525	33 New	33 $0

Others Institutions Holding TELA

# of Institutions

Shares Held

23.8M

Call Options Held

764K

Put Options Held

View Full List

About TELA Bio, Inc.

Ticker TELA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 19,157,600
Market Cap $31M
Description
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall recon...

More about TELA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account